Trophos SA - Product Pipeline Review - 2014

Date: January 31, 2014
Pages: 37
Price:
US$ 1,500.00 US$ 1,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T961CEC9EBEEN
Leaflet:

Download PDF Leaflet

Global Market Direct’s pharmaceuticals report, “Trophos SA - Product Pipeline Review - 2014” provides data on the Trophos SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Trophos SA’s corporate website, SEC filings, investor presentations and featured press releases, both from Trophos SA and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Trophos SA - Brief Trophos SA overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Trophos SA human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Trophos SA with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Trophos SA’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Trophos SA’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Trophos SA in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Trophos SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Trophos SA.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Trophos SA and identify potential opportunities in those areas.
Trophos SA Snapshot
Trophos SA Overview
Key Information
Key Facts
Trophos SA - Research and Development Overview
Key Therapeutic Areas
Trophos SA - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Trophos SA - Pipeline Products Glance
Trophos SA - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Trophos SA - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Trophos SA - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Trophos SA - Drug Profiles
olesoxime
  Product Description
  Mechanism of Action
  R&D Progress
TRO-40303
  Product Description
  Mechanism of Action
  R&D Progress
Small Molecules For Multiple Sclerosis
  Product Description
  Mechanism of Action
  R&D Progress
Small Molecules For Parkinson’s Disease
  Product Description
  Mechanism of Action
  R&D Progress
Small Molecules for Huntingtons Disease
  Product Description
  Mechanism of Action
  R&D Progress
Trophos SA - Pipeline Analysis
Trophos SA - Pipeline Products by Therapeutic Class
Trophos SA - Pipeline Products by Target
Trophos SA - Pipeline Products by Route of Administration
Trophos SA - Pipeline Products by Molecule Type
Trophos SA - Pipeline Products by Mechanism of Action
Trophos SA - Recent Pipeline Updates
Trophos SA - Dormant Projects
Trophos SA - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
olesoxime
Trophos SA - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Trophos SA, Key Information
Trophos SA, Key Facts
Trophos SA - Pipeline by Indication, 2014
Trophos SA - Pipeline by Stage of Development, 2014
Trophos SA - Monotherapy Products in Pipeline, 2014
Trophos SA - Phase III, 2014
Trophos SA - Phase II, 2014
Trophos SA - Phase I, 2014
Trophos SA - Preclinical, 2014
Trophos SA - Discovery, 2014
Trophos SA - Pipeline by Therapeutic Class, 2014
Trophos SA - Pipeline by Target, 2014
Trophos SA - Pipeline by Route of Administration, 2014
Trophos SA - Pipeline by Molecule Type, 2014
Trophos SA - Pipeline Products by Mechanism of Action, 2014
Trophos SA - Recent Pipeline Updates, 2014
Trophos SA - Dormant Developmental Projects,2014
Trophos SA - Discontinued Pipeline Products, 2014

LIST OF FIGURES

Trophos SA - Pipeline by Top 10 Indication, 2014
Trophos SA - Pipeline by Stage of Development, 2014
Trophos SA - Monotherapy Products in Pipeline, 2014
Trophos SA - Pipeline by Top 10 Therapeutic Class, 2014
Trophos SA - Pipeline by Top 10 Target, 2014
Trophos SA - Pipeline by Top 10 Route of Administration, 2014
Trophos SA - Pipeline by Top 10 Molecule Type, 2014
Trophos SA - Pipeline Products by Top 10 Mechanism of Action, 2014
Skip to top


Sickle Cell Disease - Pipeline Review, H2 2016 US$ 2,000.00 Oct, 2016 · 199 pages

Ask Your Question

Trophos SA - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: